Low Energy Blue Pulsed Light‐Activated Injectable Materials for Restoring Thinning Corneas
Authors:
Open Access
- 19 July 2023
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 33 (45)
Abstract
Many alternatives to human donor corneas are being developed to meet the global shortage of donated tissues. However, corneal transplantation remains the gold standard for diseases resulting in thinning corneas. In this study, transparent low energy photoactivated extracellular matrix‐mimicking materials are developed for intrastromal injection to restore stromal thickness. The injectable biomaterials are comprised of short peptides and glycosaminoglycans (chondroitin, hyaluronic acid) that assemble into a hydrogel when pulsed with low‐energy blue light. The dosage of pulsed‐blue light needed for material activation is minimal at 8.5 mW cm−2, thus circumventing any blue light cytotoxicity. Intrastromal injection of these light‐activated biomaterials in rat corneas shows that two iterations of the formulations remain stable in situ without stimulating significant inflammation or neovascularization. The use of low light intensities and the ability of the developed materials to stably rebuild and change the curvature of the cornea tissue make these formulations attractive for clinical translation.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada
- Canadian Institutes of Health Research (RNI00330)
This publication has 70 references indexed in Scilit:
- Photochemical Kinetics of Corneal Cross-Linking with RiboflavinInvestigative Ophthalmology & Visual Science, 2012
- Photoactivated Composite Biomaterial for Soft Tissue Restoration in Rodents and in HumansScience Translational Medicine, 2011
- A light‐activated method for repair of corneal surface defectsLasers in Surgery and Medicine, 2011
- Corneal Cross-Linking and Safety IssuesThe Open Ophthalmology Journal, 2011
- Retinal light toxicityEye, 2010
- A Biosynthetic Alternative to Human Donor Tissue for Inducing Corneal Regeneration: 24-Month Follow-Up of a Phase 1 Clinical StudyScience Translational Medicine, 2010
- Correlation between the matrix metalloproteinase-9 activity and chondroitin sulfate concentrations in tear fluid after laser in situ keratomileusisClinical Ophthalmology, 2010
- Mechanisms of Corneal Tissue Cross-linking in Response to Treatment with Topical Riboflavin and Long-Wavelength Ultraviolet Radiation (UVA)Investigative Ophthalmology & Visual Science, 2010
- Quantitative Analysis of Chondroitin Sulfate in Tear Fluids following Laser in situ KeratomileusisOphthalmic Research, 2006
- The gelatin storyJournal of Allergy and Clinical Immunology, 1999